A recent report showed that BPA-activated AHR in pancreatic islets disrupted glucose homeostasis and altered insulin sensitivity, implying that BPA-mediated AHR signaling activation plays a role in T1D development [104]. The gene discussed is INS; the disease is type 1 diabetes mellitus.